Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases

P. D. Sawin, V. C. Traynelis, K. A. Follett

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Two cases of spinal epidural hematoma following intravenous administration of recombinant tissue-type plasminogen activator are presented. Both patients received thrombolytic therapy for acute myocardial infarction; back pain and progressive neurological dysfunction ensued, secondary to spinal cord compression caused by epidural hematoma. Both individuals underwent emergency surgery for decompression and hematoma evacuation, resulting in improvement in neurological function. The current status of thrombolytic therapy is reviewed, with emphasis on complications of therapy that require neurosurgical intervention.

Original languageEnglish (US)
Pages (from-to)350-353
Number of pages4
JournalJournal of neurosurgery
Volume83
Issue number2
DOIs
StatePublished - Jan 1 1995

Fingerprint

Spinal Epidural Hematoma
Thrombolytic Therapy
Tissue Plasminogen Activator
Hematoma
Spinal Cord Compression
Back Pain
Decompression
Intravenous Administration
Emergencies
Myocardial Infarction
Therapeutics

Keywords

  • epidural hematoma
  • myocardial infarction
  • spine
  • tissue plasminogen activator

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases. / Sawin, P. D.; Traynelis, V. C.; Follett, K. A.

In: Journal of neurosurgery, Vol. 83, No. 2, 01.01.1995, p. 350-353.

Research output: Contribution to journalArticle

@article{cf3da1a53d38488291a3f8eae8ef6b57,
title = "Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases",
abstract = "Two cases of spinal epidural hematoma following intravenous administration of recombinant tissue-type plasminogen activator are presented. Both patients received thrombolytic therapy for acute myocardial infarction; back pain and progressive neurological dysfunction ensued, secondary to spinal cord compression caused by epidural hematoma. Both individuals underwent emergency surgery for decompression and hematoma evacuation, resulting in improvement in neurological function. The current status of thrombolytic therapy is reviewed, with emphasis on complications of therapy that require neurosurgical intervention.",
keywords = "epidural hematoma, myocardial infarction, spine, tissue plasminogen activator",
author = "Sawin, {P. D.} and Traynelis, {V. C.} and Follett, {K. A.}",
year = "1995",
month = "1",
day = "1",
doi = "10.3171/jns.1995.83.2.0350",
language = "English (US)",
volume = "83",
pages = "350--353",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases

AU - Sawin, P. D.

AU - Traynelis, V. C.

AU - Follett, K. A.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Two cases of spinal epidural hematoma following intravenous administration of recombinant tissue-type plasminogen activator are presented. Both patients received thrombolytic therapy for acute myocardial infarction; back pain and progressive neurological dysfunction ensued, secondary to spinal cord compression caused by epidural hematoma. Both individuals underwent emergency surgery for decompression and hematoma evacuation, resulting in improvement in neurological function. The current status of thrombolytic therapy is reviewed, with emphasis on complications of therapy that require neurosurgical intervention.

AB - Two cases of spinal epidural hematoma following intravenous administration of recombinant tissue-type plasminogen activator are presented. Both patients received thrombolytic therapy for acute myocardial infarction; back pain and progressive neurological dysfunction ensued, secondary to spinal cord compression caused by epidural hematoma. Both individuals underwent emergency surgery for decompression and hematoma evacuation, resulting in improvement in neurological function. The current status of thrombolytic therapy is reviewed, with emphasis on complications of therapy that require neurosurgical intervention.

KW - epidural hematoma

KW - myocardial infarction

KW - spine

KW - tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=0029127108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029127108&partnerID=8YFLogxK

U2 - 10.3171/jns.1995.83.2.0350

DO - 10.3171/jns.1995.83.2.0350

M3 - Article

C2 - 7616284

AN - SCOPUS:0029127108

VL - 83

SP - 350

EP - 353

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 2

ER -